可回收腔静脉滤器的临床应用研究

发布时间：2018-03-05 07:16

本文选题：可回收腔静脉滤器　切入点：静脉血栓栓塞性疾病　出处：《浙江大学》2012年硕士论文　论文类型：学位论文

【摘要】：背景可回收腔静脉滤器(Retrievable Vena Cava Filter, RVCF)是一种新型滤器,目前国内未见对RVCF使用指证、回收率及其可能影响因素的系统性临床研究,我们回顾性分析2009年6月至2011年6月在我院接受RVCF植入术的患者资料,尝试对RVCF的应用指证、回收率及其影响因素等方面进行初步探讨。方法对2009年6月至2011年6月在我院接受RVCF植入的102例患者资料进行回顾性分析,观察植入滤器的临床指证,根据是否回收滤器分为滤器回收组和滤器留置组,比较两组患者的一般资料(年龄、性别、BMI、有无高凝倾向、下肢深静脉血栓、恶性肿瘤)和植入指证,并进行统计分析。结果共有96例患者进入本次研究,其中70例成功回收滤器,尝试回收率为72.9%,回收成功率为100%。植入指证前三位分别为：抗凝禁忌(31.3%)、取/溶栓治疗(28.1%)、抗凝并发症(9.4%)。高龄(比值比0.149,95%可信区间0.034-0.651,P=0.005)、恶性肿瘤(比值比0.298,95%可信区间0.108-0.827,P=0.017)、植入指证为DVT伴抗凝失败(比值比0.061,95%可信区间0.007-0.550,P=0.001)和DVT抗凝并发症(比值比0.255,95%可信区间0.063-1.036,P=0.043)是影响RVCF回收的因素。结论 RVCF是预防肺动脉栓塞的安全有效手段。经过规范回收前评估后,RVCF具有较高的回收率。高龄、恶性肿瘤及植入指证是影响RVCF回收率的主要因素,在这些患者中使用RVCF并不比永久型腔静脉滤器更有回收优势。
[Abstract]:background
Recyclable vena cava filter (Retrievable Vena Cava Filter, RVCF) is a new type of filter, at present there is no use of RVCF to testify, the recovery rate and may affect the system of factors: a clinical study, we retrospectively analyzed from June 2009 to June 2011 treated with RVCF implantation in our hospital, try to use against RVCF the recovery and its influencing factors were discussed.
Method
The data of 102 patients from June 2009 to June 2011 underwent RVCF implantation in our hospital were retrospectively analyzed. The clinical observation that implantation of the filter, according to whether the recovery filter into the filter recovery group and filter indwelling group, compared two groups of patients with general information (age, gender, BMI, there is no hypercoagulability, deep vein thrombosis, malignant tumor) and implantation of evidence, and statistical analysis.
Result
A total of 96 patients entered the study, including 70 cases of successful recovery filter, try the rate of recovery was 72.9%, the success rate of recovery is 100%. implantation against the top three were: (31.3%), take the contraindications to anticoagulation / thrombolytic therapy (28.1%), anticoagulation complications (9.4%). Age (odds ratio 0.149,95% confidence interval 0.034-0.651, P=0.005), malignancy (odds ratio 0.298,95% CI 0.108-0.827, P=0.017), charged with DVT implantation anticoagulation failure (odds ratio 0.061,95% CI 0.007-0.550, P=0.001) and DVT anticoagulation complications (odds ratio 0.255,95% CI 0.063-1.036, P=0.043) is the influence factors of RVCF recovery.
conclusion
RVCF is a safe and effective method in the prevention of pulmonary embolism. After evaluating standard recycling before and after recovery. RVCF has a higher rate of elderly, malignant tumor and implantation that is the main factor affecting the recovery rate of RVCF, the use of RVCF in these patients is not better than permanent cava filter recovery more advantages.

【学位授予单位】：浙江大学
【学位级别】：硕士
【学位授予年份】：2012
【分类号】：R563.5

【共引文献】